A study published in the Journal of Hepatology looked at a DAA regimen in patients with a history of poor adherence or treatment interruption, as well as in patients with HIV/HCV coinfection. The RESOLVE study aimed to assess the safety and efficacy of this combination in patients with HCV infection Read more…
Washington, DC – Today, the House of Representatives passed two amendments that would provide $20 million in additional funding to programs that will prevent new cases of HIV and viral hepatitis stemming from the nation’s opioid epidemic and improve HIV prevention and care services in minority communities. As part of its Read more…
Want to contribute to national health research? The All of Us Research Program is an exciting initiative from the National Institutes of Health. The goal is simple: to speed up health research and medical breakthroughs by building one of the largest health databases of its kind. To do this, the PA research program Read more…
Pennsylvania officials declared an outbreak of hepatitis A in the state on Monday, citing 171 cases that have been reported since January 2018 in 36 counties, including Philadelphia. The declaration makes Pennsylvania eligible for federal funds to purchase additional doses of a vaccine against the liver disease, whose symptoms can Read more…
June 7th @ 12:00 PM – Register here! Join HepCAP co-chair Dr. Stacey Trooskin, Director of Viral Hepatitis Programs at Philadelphia FIGHT Community Health Centers and Clinical Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, as she discusses Barriers to care for injection Read more…
Sunday, May 19th was National Hepatitis Testing Day, a great opportunity to spread the word to patients, providers, and entire communities about the importance of being tested for hepatitis. We encourage everyone to know their status and believe every single day should be National Hepatitis Testing Day! The CDC’s four Read more…
The Pennsylvania Department of Health (DOH) is seeking nominations for the Viral Hepatitis Elimination Planning Committee. This volunteer committee will be comprised of a broad range of viral hepatitis stakeholders from across the state of Pennsylvania. DOH is seeking self-nominations from individuals with a variety of expertise to ensure a Read more…
How will you go H.A.M.? We have some ideas… **Know of any other events and webinars to celebrate Hepatitis Awareness Month? Is your organizing conducting screening or awareness events? Let us know (e-mail priyanka.padidam@phila.gov) and we’ll publicize it.** **Calendar of Events and Webinars** Friday 5/10 is the last day to apply for the NVHR Read more…
The House Appropriations Committee has released its budget proposal for the fiscal year 2020, affecting viral hepatitis through increased funding and awareness. View the full report here and the excerpted portions below. Infectious Diseases and the Opioid Epidemic.—The Committee includes an increase of $15,000,000 to strengthen efforts to conduct surveillance Read more…
View the April 30 press release from the FDA here. The U.S. Food and Drug Administration approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously approved to treat HCV in adults in 2017. “Direct-acting Read more…